immunotherapy
209 projects
HEIndividual fellowship2027–2029France
IT-PREDICT · Predicting immunotherapy response in melanoma and non-small cell lung cancer patients using an extracellular vesicle-derived miRNA signature and a non-invasive CRISPR-based detection assay.
HEIndividual fellowship2027–2029Belgium
LipoTAME · Harnessing engineered lipid nanoparticles to tame autoimmune neuroinflammation by inducing regulatory T cells through CNS myeloid reprogramming
HEIndividual fellowship2027–2028Austria
GlycoIMPACT · Glycoengineering for Immune Modulation in Precision Anti-Cancer Therapies
2 partners · 2 countries
HEIndividual fellowship2027–2028United Kingdom
TS-ATM · T cell suppression by antioxidant proteins released into the tumour microenvironment
HEDoctoral network2026–2030Netherlands
ORFeus · Decoding the dark proteome through interdisciplinary training and research
33 partners · 12 countries
HEIndividual fellowship2026–2028Switzerland
ONCAR-TRAIL · TRAIL-armed CAR T cells in combination with ONC206 for diffuse midline gliomas
2 partners
HEIndividual fellowship2026–2029Portugal
NK_LIC2CLUSTER_SR1 · Decoding NK Cell Licensing Through Programmable Nanoscale Clustering and Spatial Mapping
2 partners · 2 countries
HEIndividual fellowship2026–2028Ireland
FluorNano · Fluorinated polymer nanoparticles for mRNA-based cancer therapy
2 partners · 2 countries
HEStaff exchange2026–2029Netherlands
LIGHTHER · First-in-kind anticancer therapy combining light-controllable cytotoxic peptides and dendritic cell-based immunotherapy
6 partners · 3 countries
HEStaff exchange2026–2030Italy
GlioZERO · Advanced technologies for zeroing in on high-grade gliomas
11 partners · 5 countries
HEIndividual fellowship2026–2028Netherlands
T-REaCT · Evolution of T cell reactivity against somatic mutations across human colon cancer stages with single-cell genomics and synthetic T cell specificity screening
3 partners · 2 countries
HEIndividual fellowship2026–2028Luxembourg
LINK-M · Investigating the Interplay of Natural Killer Cells and Microbiome in Non-Hodgkin's Lymphoma
HEIndividual fellowship2026–2028Germany
SIMPL · Spectral Interpretability for Molecular Potentials Learning with Graph Neural Networks
HEIndividual fellowship2026–2028Netherlands
X-CITE · Uncovering the Role of X Chromsome Inactivation Escapees in T Cell Function
HEIndividual fellowship2025–2027Spain
RADIANT-HOPE · Radiomic Analysis and Data Insights for Enhancing Hepatocellular Carcinoma Immunotherapy Outcomes
HEIndividual fellowship2025–2027Sweden
ExpandTILs · Reprogramming cancer cells in dendritic cells to expand tumor-reactive infiltrating lymphocytes.
HEIndividual fellowship2025–2027Portugal
cDcIVA · Nutritional Retinoic Acid as an early cDC2A fate instructive signal in the bone marrow
HEIndividual fellowship2025–2027Italy
RAMPART · Label-Free Raman Approaches for Patient-Specific Biochemical Tumor Mapping to Monitor Personalized Anticancer Resistance Simulation
3 partners · 3 countries
HEIndividual fellowship2025–2028United Kingdom
VASPRINT · Designing Vascular Geometries in 3D Bioprinted Models for Immuno-oncology
2 partners · 2 countries
HEIndividual fellowship2025–2027France
Bio3XBRIT · Unraveling mechanisms of immunotherapy resistance through biomarker profiling in triple-negative breast cancer
HEIndividual fellowship2025–2027Spain
PEPTIM · PEptides Promoting Tolerogenic Interactions with Microbiota
HEIndividual fellowship2025–2027Spain
STRIM-HCC · Defining the role of stromal cells in determining HCC patient response to immunotherapies at single-cell resolution
HEIndividual fellowship2025–2027Germany
TLRT · Enhancing immunotherapies against solid tumors with TLR-switch receptor-armored T cells (TLR-T cells)
HEIndividual fellowship2025–2027Ireland